As we begin to reopen Rush University Medical Center for elective procedures and in-person care, we are putting your safety first. For information about COVID-19, see the latest updates. Rush accepts donations to support our response effort, staff, and patients and families.

Excellence is just the beginning.


French German Italian Portuguese Russian

Depression Treatment Study

Clinical Trial Title: 
Rush depression trials
Clinical Trial Protocol ID: 
Clinical Trial Investigator Name: 
John Zajecka, MD
Clinical Trial Protocol Description: 

Rush is conducting a number of research trials in the area of depression. A clinical evaluation will be conducted to determine whether one of our research protocols is appropriate for you. If they are, you will be randomly assigned to a treatment group. A number of different research protocols are available, all involving drug treatment. Study drugs may be FDA-approved or investigational (not FDA-approved), and some studies may involve a placebo.

Study procedures, visits and drugs will be provided at no cost to participants. Participants must be able to come to the clinic for frequent visits between during business hours, Monday through Friday. We have sites in Chicago and Skokie.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Are currently experiencing symptoms of depression, including feeling sad, blue, hopeless or worthless; crying spells; trouble sleeping or sleeping too much; unexplained low energy or fatigue; difficulty concentrating; loss of interest or pleasure; changes in weight or appetite; wondering if life is worth living.
  • Have no serious or untreated medical illnesses.
  • Be between the ages of 18 and 65.
  • Meet other eligibility requirements as outlined by research protocols.

This is a partial list of inclusion criteria.

Clinical Trial Area: 
Mental Health Disorders
Contact Phone: 
(312) 942-6597
Contact Name: 
Treatment Research Center